Accueil > Fr > Rech & Devpt > Publications > 2009


Articles :

  • Alliot C., Chérel M., Barbet J., Sauvage T., Montavon G. Extraction of astatine-211 in diisopropylether (DIPE). Radiochim. Acta. 2009, 97, 161–165.
  • Alliot I, Alliot C, Vitorge P, Fattahi M. Speciation of Technetium(IV) in Bicarbonate Media. Environ Sci Technol, 2009, 43, 9174-9182.
  • Ansquer, C., Kraeber-Bodéré, F., Chatal, J.F. Current status and perspectives in peptide receptor radiation therapy. Curr Pharm Des., 2009, 15 : 2453-2462.
  • Barbet J, Chatal JF, Kraeber-Bodéré F. Les anticorps radiomarqués pour le traitement des cancers. Med Sci (Paris). 2009, 25, 1039-1045.
  • Champion J, Alliot C, Huclier S, Deniaud D, Asfari Z, Montavon, G. Determination of stability constants between complexing agents and At(I) and At(III) species present at ultra-trace concentrations. Inorg Chim Acta. 2009, 362, 2654-2661.
  • Chatal J.F., Davodeau F., Chérel M., Barbet J. Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors. J Cancer Res Ther, 2009, 5, S36-S40.
  • Kraeber-Bodéré, F., Goldenberg, D.M., Chatal, J.F., Barbet, J. Current Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer. Current Oncology, 2009, 16, 3-8.